SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
- Status
- RECRUITING
- Phase
- PHASE2
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Status
- RECRUITING
- Phase
- PHASE2